Derek Archila
Stock Analyst at Wells Fargo
(4.89)
# 283
Out of 4,456 analysts
920
Total ratings
56.9%
Success rate
21.6%
Average return
Main Sectors:
Stocks Rated by Derek Archila
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GLUE Monte Rosa Therapeutics | Rated: Buy | $29 | $22.29 | +30.10% | 17 | Jun 24, 2026 | |
| INCY Incyte | Maintained: Hold | $101 | $113.75 | -11.21% | 39 | Jun 17, 2026 | |
| VRDN Viridian Therapeutics | Maintained: Hold | $20 | $17.90 | +11.73% | 17 | Jun 17, 2026 | |
| ASND Ascendis Pharma | Maintained: Buy | $326 | $260.75 | +25.02% | 44 | Jun 17, 2026 | |
| ARGX argenx SE | Maintained: Buy | $1,291 | $887.18 | +45.52% | 75 | Jun 17, 2026 | |
| RYTM Rhythm Pharmaceuticals | Rated: Buy | $144 → $155 | $109.84 | +41.11% | 60 | Jun 17, 2026 | |
| SEPN Septerna | Maintained: Buy | $48 | $37.34 | +28.55% | 11 | Jun 17, 2026 | |
| ORIC ORIC Pharmaceuticals | Rated: Buy | $25 | $9.53 | +162.33% | 12 | Jun 11, 2026 | |
| NRIX Nurix Therapeutics | Downgraded: Hold | $28 → $25 | $22.90 | +9.17% | 23 | Jun 9, 2026 | |
| TRAX First Tracks Biotherapeutics | Initiated Coverage: Buy | $30 | $16.03 | +87.15% | 1 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $8.00 | +87.50% | 25 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $38.85 | +15.83% | 29 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $1 | $0.5275 | +89.57% | 12 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 → $51 | $26.40 | +93.18% | 8 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $38 → $54 | $35.26 | +53.15% | 19 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $4.26 | +134.74% | 13 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $33 | $8.44 | +291.00% | 13 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 | $70.24 | +39.52% | 6 | May 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $35 | $54.77 | -36.10% | 28 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $5.48 | +392.70% | 19 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $2.04 | +145.10% | 1 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 | $13.17 | -24.07% | 7 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $78 → $79 | $74.78 | +5.64% | 4 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $116 | $108.12 | +7.29% | 22 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $479 → $376 | $291.37 | +29.05% | 4 | Jan 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $56 | $60.53 | -7.48% | 4 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $81 | $63.15 | +28.27% | 27 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $73 | $84.43 | -13.54% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 | $31.99 | +215.72% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $78.17 | -60.34% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $40 → $30 | $30.52 | -1.70% | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $2 | $3.04 | -34.21% | 16 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 | $24.15 | -42.03% | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $4.04 | +23.76% | 17 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $180 | $69.91 | n/a | 1 | Dec 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $11.39 | $1.32 | n/a | 1 | Dec 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $3.05 | n/a | 11 | Jun 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $0.43 | n/a | 34 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $9.42 | n/a | 20 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $34.54 | n/a | 27 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $96 → $97 | $29.50 | n/a | 15 | May 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $126 → $130 | $512.65 | n/a | 10 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $37 → $20 | $3.17 | n/a | 24 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $6 | $16.01 | n/a | 20 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $15.91 | n/a | 28 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $38.04 | n/a | 11 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €15.85 → €16.73 | $3.07 | n/a | 2 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $19 | $3.41 | n/a | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €291.43 → €293.19 | $785.40 | n/a | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €92.45 → €96.00 | $25.80 | n/a | 2 | Feb 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €11.00 | $10.16 | n/a | 7 | Sep 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $25.24 | n/a | 14 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.01 | n/a | 31 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $13.52 | n/a | 12 | Apr 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.0015 | n/a | 11 | Mar 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 | $9.95 | n/a | 6 | Mar 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $33.21 | n/a | 18 | Feb 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.08 | n/a | 8 | Nov 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $16.33 | n/a | 1 | Oct 3, 2017 |
Monte Rosa Therapeutics
Jun 24, 2026
Rated: Buy
Price Target: $29
Current: $22.29
Upside: +30.10%
Incyte
Jun 17, 2026
Maintained: Hold
Price Target: $101
Current: $113.75
Upside: -11.21%
Viridian Therapeutics
Jun 17, 2026
Maintained: Hold
Price Target: $20
Current: $17.90
Upside: +11.73%
Ascendis Pharma
Jun 17, 2026
Maintained: Buy
Price Target: $326
Current: $260.75
Upside: +25.02%
argenx SE
Jun 17, 2026
Maintained: Buy
Price Target: $1,291
Current: $887.18
Upside: +45.52%
Rhythm Pharmaceuticals
Jun 17, 2026
Rated: Buy
Price Target: $144 → $155
Current: $109.84
Upside: +41.11%
Septerna
Jun 17, 2026
Maintained: Buy
Price Target: $48
Current: $37.34
Upside: +28.55%
ORIC Pharmaceuticals
Jun 11, 2026
Rated: Buy
Price Target: $25
Current: $9.53
Upside: +162.33%
Nurix Therapeutics
Jun 9, 2026
Downgraded: Hold
Price Target: $28 → $25
Current: $22.90
Upside: +9.17%
First Tracks Biotherapeutics
Jun 8, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $16.03
Upside: +87.15%
May 22, 2026
Maintained: Buy
Price Target: $15
Current: $8.00
Upside: +87.50%
May 21, 2026
Reiterated: Buy
Price Target: $45
Current: $38.85
Upside: +15.83%
May 18, 2026
Rated: Hold
Price Target: $1
Current: $0.5275
Upside: +89.57%
May 15, 2026
Reiterated: Buy
Price Target: $49 → $51
Current: $26.40
Upside: +93.18%
May 13, 2026
Rated: Buy
Price Target: $38 → $54
Current: $35.26
Upside: +53.15%
May 13, 2026
Rated: Buy
Price Target: $10
Current: $4.26
Upside: +134.74%
May 12, 2026
Rated: Buy
Price Target: $33
Current: $8.44
Upside: +291.00%
May 9, 2026
Reiterated: Buy
Price Target: $98
Current: $70.24
Upside: +39.52%
Apr 14, 2026
Maintained: Hold
Price Target: $35
Current: $54.77
Upside: -36.10%
Apr 1, 2026
Reiterated: Buy
Price Target: $27
Current: $5.48
Upside: +392.70%
Mar 19, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $2.04
Upside: +145.10%
Mar 11, 2026
Maintained: Hold
Price Target: $10
Current: $13.17
Upside: -24.07%
Mar 2, 2026
Maintained: Buy
Price Target: $78 → $79
Current: $74.78
Upside: +5.64%
Mar 2, 2026
Maintained: Buy
Price Target: $116
Current: $108.12
Upside: +7.29%
Jan 20, 2026
Maintained: Hold
Price Target: $479 → $376
Current: $291.37
Upside: +29.05%
Dec 16, 2025
Maintained: Sell
Price Target: $56
Current: $60.53
Upside: -7.48%
Dec 16, 2025
Maintained: Buy
Price Target: $51 → $81
Current: $63.15
Upside: +28.27%
Oct 17, 2025
Maintained: Buy
Price Target: $73
Current: $84.43
Upside: -13.54%
Oct 17, 2025
Maintained: Buy
Price Target: $101
Current: $31.99
Upside: +215.72%
Oct 17, 2025
Maintained: Buy
Price Target: $31
Current: $78.17
Upside: -60.34%
Aug 12, 2025
Maintained: Hold
Price Target: $40 → $30
Current: $30.52
Upside: -1.70%
Aug 8, 2025
Maintained: Hold
Price Target: $3 → $2
Current: $3.04
Upside: -34.21%
Aug 7, 2025
Maintained: Hold
Price Target: $14
Current: $24.15
Upside: -42.03%
Aug 6, 2025
Maintained: Hold
Price Target: $6 → $5
Current: $4.04
Upside: +23.76%
Dec 6, 2021
Initiated Coverage: Buy
Price Target: $180
Current: $69.91
Upside: n/a
Dec 6, 2021
Initiated Coverage: Sell
Price Target: $11.39
Current: $1.32
Upside: n/a
Jun 13, 2021
Rated: Buy
Price Target: $12
Current: $3.05
Upside: n/a
May 13, 2021
Reiterated: Buy
Price Target: $27
Current: $0.43
Upside: n/a
May 13, 2021
Reiterated: Hold
Price Target: $3
Current: $9.42
Upside: n/a
May 13, 2021
Reiterated: Buy
Price Target: $30
Current: $34.54
Upside: n/a
May 9, 2021
Reiterated: Hold
Price Target: $96 → $97
Current: $29.50
Upside: n/a
May 6, 2021
Reiterated: Hold
Price Target: $126 → $130
Current: $512.65
Upside: n/a
May 4, 2021
Downgraded: Hold
Price Target: $37 → $20
Current: $3.17
Upside: n/a
May 3, 2021
Reiterated: Hold
Price Target: $7 → $6
Current: $16.01
Upside: n/a
Apr 29, 2021
Reiterated: Hold
Price Target: $6
Current: $15.91
Upside: n/a
Apr 28, 2021
Reiterated: Buy
Price Target: $13
Current: $38.04
Upside: n/a
Mar 5, 2021
Maintained: Buy
Price Target: €15.85 → €16.73
Current: $3.07
Upside: n/a
Mar 5, 2021
Reiterated: Buy
Price Target: $18 → $19
Current: $3.41
Upside: n/a
Mar 4, 2021
Maintained: Hold
Price Target: €291.43 → €293.19
Current: $785.40
Upside: n/a
Feb 19, 2021
Maintained: Hold
Price Target: €92.45 → €96.00
Current: $25.80
Upside: n/a
Sep 30, 2020
Reiterated: Buy
Price Target: €11.00
Current: $10.16
Upside: n/a
Jul 10, 2020
Rated: Hold
Price Target: n/a
Current: $25.24
Upside: n/a
Jul 10, 2020
Rated: Hold
Price Target: n/a
Current: $6.01
Upside: n/a
Apr 2, 2018
Reiterated: Buy
Price Target: $13
Current: $13.52
Upside: n/a
Mar 22, 2018
Maintained: Buy
Price Target: n/a
Current: $0.0015
Upside: n/a
Mar 5, 2018
Reiterated: Buy
Price Target: $98
Current: $9.95
Upside: n/a
Feb 8, 2018
Rated: Hold
Price Target: n/a
Current: $33.21
Upside: n/a
Nov 9, 2017
Maintained: Hold
Price Target: n/a
Current: $1.08
Upside: n/a
Oct 3, 2017
Maintained: Hold
Price Target: n/a
Current: $16.33
Upside: n/a